Algorithms for systemic therapy of prostate cancer, transitional cell carcinoma and renal cell carcinoma

被引：0
|
作者：
Eisenhardt, A. [1 ,2 ]
Ohlmann, C-H [3 ]
Doehn, C. [4 ,5 ]
机构：
[1] Praxiskliniken Urol Rhein Ruhr, Schulstr 11, D-45468 Mulheim, Germany
[2] Univ Klinikum Essen, Klin & Poliklin Urol Kinderurol & Uroonkol, Essen, Germany
[3] Malteser Krankenhaus Seliger Gerhard Bonn, Klin Urol, Bonn, Germany
[4] Urologikum Lubeck, Lubeck, Germany
[5] Deutsch Uroonkologen D Uo, Berlin, Germany
来源：
UROLOGE | 2020年 / 59卷 / 05期
关键词：
Androgene deprivation; Combination therapy; Drug-related side effects; Chemotherapy; Hormone suppression; METASTATIC UROTHELIAL CARCINOMA; CISPLATIN-INELIGIBLE PATIENTS; PHASE-III TRIAL; PLUS PREDNISONE; SINGLE-ARM; ANDROGEN-DEPRIVATION; VINFLUNINE PLUS; SUPPORTIVE CARE; SURVIVAL; MULTICENTER;
D O I：
10.1007/s00120-020-01182-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Systemic therapy in uro-oncology is currently undergoing major changes. In the past, drug therapies only showed good treatment results in metastasized testicular tumors. New developments indicate that an improved understanding of tumor biology will lead to targeted treatment strategies for metastatic prostate, urothelial and renal cell carcinoma. In the following article, we summarize the practice-relevant innovations in systemic therapy in the guidelines on prostate cancer, transitional cell carcinoma of the bladder and renal cell carcinoma.
引用
收藏
页码：533 / 542
页数：10
相关论文
共 50 条
  • [21] Systemic therapy of metastatic renal cell carcinoma
    Maute, Luise
    Bergmann, Lothar
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (07) : 466 - 469
  • [22] Promising systemic therapy for renal cell carcinoma
    Cooney M.M.
    Remick S.C.
    Vogelzang N.J.
    Current Treatment Options in Oncology, 2005, 6 (5) : 357 - 365
  • [23] Systemic therapy of metastasizing renal cell carcinoma
    Staehler, M.
    Haseke, N.
    Zilinberg, K.
    Stadler, T.
    Karl, A.
    Stief, C. G.
    UROLOGE, 2008, 47 (10): : 1357 - 1365
  • [24] Perioperative systemic therapy in renal cell carcinoma
    Macphail, Ceilidh
    Wood, Lori A.
    Thana, Myuran
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2023, 17 (04) : 301 - 307
  • [25] Systemic therapy in metastatic renal cell carcinoma
    Jens Bedke
    Thomas Gauler
    Viktor Grünwald
    Axel Hegele
    Edwin Herrmann
    Stefan Hinz
    Jan Janssen
    Stephan Schmitz
    Martin Schostak
    Hans Tesch
    Stefan Zastrow
    Kurt Miller
    World Journal of Urology, 2017, 35 : 179 - 188
  • [26] Systemic therapy of metastatic renal cell carcinoma
    Maute, L.
    Bergmann, L.
    ONKOLOGE, 2015, 21 (01): : 35 - +
  • [27] Systemic therapy in metastatic renal cell carcinoma
    Bedke, Jens
    Gauler, Thomas
    Gruenwald, Viktor
    Hegele, Axel
    Herrmann, Edwin
    Hinz, Stefan
    Janssen, Jan
    Schmitz, Stephan
    Schostak, Martin
    Tesch, Hans
    Zastrow, Stefan
    Miller, Kurt
    WORLD JOURNAL OF UROLOGY, 2017, 35 (02) : 179 - 188
  • [28] Clinical study of transitional cell carcinoma of the prostate associated with bladder transitional cell carcinoma
    Honda, N
    Yamada, Y
    Okada, M
    Aoki, S
    Kamijyo, A
    Taki, T
    Mitsui, K
    Hibi, H
    Fukatsu, H
    INTERNATIONAL JOURNAL OF UROLOGY, 2001, 8 (12) : 662 - 668
  • [29] Update on systemic therapy for clear cell renal cell carcinoma
    Josef Mühlmann
    memo - Magazine of European Medical Oncology, 2023, 16 : 38 - 41
  • [30] Update on systemic therapy for clear cell renal cell carcinoma
    Muehlmann, Josef
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (01) : 38 - 41
12345